Epidemiology of Hepatitis B and C Viruses: A Global Overview

Clinics in Liver Disease

Volumn 14, Issue 1, 2010, Pages 1-21

  Te, Helen S ^a   Jensen, Donald M ^b  

^a Center for Liver Diseases   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Endemicity; Epidemiology; Global; Hepatitis B; Hepatitis C

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

AFRICA; ASIA; BLOOD DONOR; CANCER RISK; CENTRAL AMERICA; DISEASE COURSE; DISEASE SEVERITY; DNA VIRUS; EGYPT; ENDEMIC DISEASE; EUROPE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; NONHUMAN; NORTH AMERICA; PREVALENCE; REVIEW; RISK FACTOR; RNA VIRUS; SOUTH AMERICA; SOUTHEAST ASIA; UNITED STATES; VACCINATION; VIRAL GENETICS; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MOLECULAR EPIDEMIOLOGY; WORLD HEALTH;

EID: 74549128529     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2009.11.009     Document Type: Review

References (130)

1. WHO. Global immunization data. 2009. Available at:. http://www.who.int/immunization/newsroom/GID_english.pdf Accessed February 1, 2009
2. Perz J.F., Armstrong G.L., Farrington L.A., et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45 4 (2006) 529-538
3. WHO. Hepatitis B vaccines. Wkly Epidemiol Rec 79 28 (2004) 253-264
4. CDC. Epidemiology and prevention of vaccine-preventable diseases (The pink book). 10th edition (2008), Public Health Foundation, Waldorf (MD)
5. Schaefer S. Hepatitis B virus genotypes in Europe. Hepatol Res 37 S1 (2007) S20-S26
6. Devesa M., and Pujol F.H. Hepatitis B virus genetic diversity in Latin America. Virus Res 127 2 (2007) 177-184
7. Lai C.L., Ratziu V., Yuen M.F., et al. Viral hepatitis B. Lancet 362 9401 (2003) 2089-2094
8. Wai C.T., and Fontana R.J. Clinical significance of hepatitis B virus genotypes, variants, and mutants. Clin Liver Dis 8 2 (2004) 321-352 vi
9. Fung S.K., and Lok A.S. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?. Hepatology 40 4 (2004) 790-792
10. Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13 (2005) 14-21
11. Rantala M., and van de Laar M.J.W. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Euro Surveill 13 4-6 (2008) 1-8
12. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat 12 2 (2005) 111-124
13. Kao J.H. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 17 6 (2002) 643-650
14. Glynn S.A., Kleinman S.H., Schreiber G.B., et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 284 2 (2000) 229-235
15. US CDC. Disease burden from hepatitis A, B and C. Available at:. http://www.cdc.gov/Hepatitis/Statistics.htm#section1 Accessed March 9, 2009
16. McMahon B.J., Schoenberg S., Bulkow L., et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. Am J Epidemiol 138 7 (1993) 544-549
17. Smith N., Yusuf H., and Averhoff F. Surveillance and prevention of hepatitis B virus transmission. Am J Public Health 89 1 (1999) 11-13
18. Euler G.L., Wooten K.G., Baughman A.L., et al. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 111 5 Part 2 (2003) 1192-1197
19. Public Health Agency of Canada. Hepatitis B factsheet. Available at:. http://www.phac-aspc.gc.ca/hcai-iamss/bbp-pts/hepatitis/hep_b-eng.php Accessed March 3, 2009
20. Public Health Agency of Canada. Canadian immunization guide, 7th edition, 2006. Available at: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-hepb-eng.php. Accessed March 3, 2009.
21. Zhang J., Zou S., and Giulivi A. Epidemiology of hepatitis B in Canada. Can J Infect Dis 12 6 (2001) 345-350
22. Custer B., Sullivan S.D., Hazlet T.K., et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38 10 Suppl 3 (2004) S158-S168
23. Silveira T.R., da Fonseca J.C., Rivera L., et al. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica 6 6 (1999) 378-383
24. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 18 Suppl 1 (2000) S17-S19
25. Fay O.H. Hepatitis B in Latin America: epidemiologic patterns and eradication strategy. The Latin American Regional Study Group. Vaccine 8 Suppl (1990) 86-92
26. Torres J. Hepatitis B and hepatitis delta virus infection in South America. Gut 38 Suppl 2 (1996) S48-S55
27. Gish R.G., and Gadano A.C. Chronic hepatitis B: current epidemiology in the Americas and implications for management. J Viral Hepat 13 12 (2006) 787-798
28. Torres J.R., and Machado I.V. Special aspects of hepatitis B virus and delta virus infection in Latin America. Infect Dis Clin North Am 8 1 (1994) 13-27
29. Torres J.R., and Mondolfi A. Protracted outbreak of severe delta hepatitis: experience in an isolated Amerindian population of the Upper Orinoco basin. Rev Infect Dis 13 1 (1991) 52-55
30. Kiire C. Hepatitis B infection in sub-Saharan Africa: the African regional Study Group. Vaccine 8 (1990) 107-112
31. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000. The global picture. Eur J Cancer 37 Suppl 8 (2001) S4-66
32. Kirk G.D., Lesi O.A., Mendy M., et al. The gambia liver cancer study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39 1 (2004) 211-219
33. Kew M.C. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 38 Suppl 2 (1996) S31-S36
34. Sall Diallo A., Sarr M., Fall Y., et al. [Hepatitis B infection in infantile population of Senegal]. Dakar Med 49 2 (2004) 136-142 [in French]
35. Coursaget P., Leboulleux D., Yvonnet B., et al. Hepatitis B virus infection and hepatocellular carcinoma in Senegal: prevalence and prevention. J Gastroenterol Hepatol 8 (1993) s128-s133
36. Roingeard P., Diouf A., Sankale J.L., et al. Perinatal transmission of hepatitis B virus in Senegal, West Africa. Viral Immunol 6 1 (1993) 65-73
37. Marinier E., Barrois V., Larouze B., et al. Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. J Pediatr 106 5 (1985) 843-849
38. Whittle H., Inskip H., Bradley A.K., et al. The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis 161 6 (1990) 1112-1115
39. Kiire C. The epidemiology and control of hepatitis B in sub-Saharan Africa. Prog Med Virol 40 (1993) 141-156
40. Pawlotsky J.M., Belec L., Gresenguet G., et al. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol 46 3 (1995) 269-272
41. Edmunds W.J., Medley G.F., Nokes D.J., et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 117 2 (1996) 313-325
42. Akani C.I., Ojule A.C., Opurum H.C., et al. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J 12 4 (2005) 266-270
43. Oshitani H., Kasolo F.C., Mpabalwani M., et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 90 3 (1996) 235-236
44. Viviani S., Carrieri P., Bah E., et al. 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev 17 11 (2008) 3216-3223
45. Tsebe K.V., Burnett R.J., Hlungwani N.P., et al. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 19 28-29 (2001) 3919-3926
46. Lehman E.M., and Wilson M.L. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer 124 3 (2009) 690-697
47. Sherif M.M., Abou-Aita B.A., Abou-Elew M.H., et al. Hepatitis B virus infection in upper and lower Egypt. J Med Virol 15 2 (1985) 129-135
48. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 10 (1988) 1942-1956
49. 9M suffering from hepatitis C, Senate told, in The News International. Islamabad, 2009. Available at:. http://www.thenews.com.pk/print1.asp?id=166167 Accessed March 8, 2009
50. Khattak M.F., Salamat N., Bhatti F.A., et al. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 52 9 (2002) 398-402
51. Butt T., and Amin M.S. Seroprevalence of hepatitis B and C infections among young adult males in Pakistan. East Mediterr Health J 14 4 (2008) 791-797
52. Alizadeh A.H., Ranjbar M., Ansari S., et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J 12 5 (2006) 528-537
53. Goudeau A. Epidemiology and eradication strategy for hepatitis B in Europe. The European Regional Study Group. Vaccine 8 Suppl (1990) S113-S116 [discussion: S134-8]
54. ECDC. Hepatitis B: epidemiological situation. Available at:. http://www.ecdc.europa.eu/en/Health_Topics/hepatitis/hepatitisB/aer_07.aspx Accessed March 4, 2009
55. WHO regional office for Europe, hepatitis B, 2007. Available at:. http://data.euro.who.int/cisid/?TabID=197787 Accessed March 4, 2009
56. Fabris P., Baldo V., Baldovin T., et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol 42 5 (2008) 527-532
57. Veldhuijzen I.K., Smits L.J., and van de Laar M.J. The importance of imported infections in maintaining hepatitis B in The Netherlands. Epidemiol Infect 133 1 (2005) 113-119
58. Linglof T.O. Hepatitis B in parts of former USSR. Scand J Infect Dis 27 3 (1995) 299-300
59. Magdzik W.W. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine 18 Suppl 1 (2000) S13-S16
60. Adamo B., Stroffolini T., Sagliocca L., et al. Ad hoc survey of hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in 12-year-old subjects in southern Italy. Vaccine 16 8 (1998) 775-777
61. Mele A., Tancredi F., Romano L., et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 184 7 (2001) 905-908
62. Stroffolini T., Mele A., Tosti M.E., et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 33 6 (2000) 980-985
63. Tanprasert S., and Somjitta S. Trend study on HbsAg prevalence in Thai voluntary blood donors. Southeast Asian J Trop Med Public Health 24 Suppl 1 (1993) S43-S45
64. Chub-uppakarn S., Panichart P., Theamboonlers A., et al. Impact of the hepatitis B mass vaccination program in the southern part of Thailand. Southeast Asian J Trop Med Public Health 29 3 (1998) 464-468
65. Luksamijarulkul P., Thammata N., and Tiloklurs M. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand. Southeast Asian J Trop Med Public Health 33 2 (2002) 272-279
66. Luksamijarulkul P., Watagulsin P., and Sujirarat D. Hepatitis B virus seroprevalence and risk assessment among personnel of a governmental hospital in Bangkok. Southeast Asian J Trop Med Public Health 32 3 (2001) 459-465
67. Pramoolsinsap C., Pukrittayakamee S., and Desakorn V. Hepatitis B problem in Thailand. Southeast Asian J Trop Med Public Health 17 2 (1986) 219-228
68. Tandon B.N., Acharya S.K., and Tandon A. Epidemiology of hepatitis B virus infection in India. Gut 38 Suppl 2 (1996) S56-S59
69. WHO regional office for South-East Asia, India. Core program clusters. Family and community health. Hepatitis B. Available at:. http://www.whoindia.org/EN/Section6/Section8_26.htm#a4 Accessed March 6, 2009
70. WHO regional office for South-East Asia. Prevention of hepatitis B in India, New Delhi, August 2002. Available at:. http://whqlibdoc.who.int/searo/2002/SEA_Hepat.-5.pdf Accessed March 6, 2009
71. John T.J., and Abraham P. Hepatitis B in India: a review of disease epidemiology. Indian Pediatr 38 11 (2001) 1318-1325
72. Chowdhury A., Santra A., Chaudhuri S., et al. Prevalence of hepatitis B infection in the general population: a rural community based study. Trop Gastroenterol 20 2 (1999) 75-77
73. Gust I.D. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38 Suppl 2 (1996) S18-S23
74. Lingao A.L., Domingo E.O., West S., et al. Seroepidemiology of hepatitis B virus in the Philippines. Am J Epidemiol 123 3 (1986) 473-480
75. Lansang M.A. Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia. Gut 38 Suppl 2 (1996) S43-S47
76. Lin H.H., Kao J.H., Chang T.C., et al. Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol 69 4 (2003) 466-470
77. Yao G.B. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 38 Suppl 2 (1996) S39-S42
78. Chang M.H., Chen C.J., Lai M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N Engl J Med 336 26 (1997) 1855-1859
79. Huang K., and Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine 18 Suppl 1 (2000) S35-S38
80. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV related chronic disease. MMWR Recomm Rep 47 RR-19 (1998) 1-39
81. WHO. Hepatitis C, WHO fact sheet no. 164, revised 2000. Available at:. http://www.who.int/mediacentre/factsheets/fs164/en/ Accessed March 8, 2009
82. Alter M.J. Epidemiology of hepatitis C virus infection. World J Gastroenterol 13 17 (2007) 2436-2441
83. Houghton M. Hepatitis C viruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields virology. 3rd edition (1996), Lippincott-Raven, Philadelphia 1036-1058
84. Mondelli M.U., and Silini E. Clinical significance of hepatitis C virus genotypes. J Hepatol 31 Suppl 1 (1999) 65-70
85. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6 1 (1999) 35-47
86. Nguyen M.H., and Keeffe E.B. Chronic hepatitis C: genotypes 4 to 9. Clin Liver Dis 9 3 (2005) 411-426 vi
87. Kamal S.M., and Nasser I.A. Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology 47 4 (2008) 1371-1383
88. Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 10 (2006) 705-714
89. Public Health Agency of Canada. Evaluation of the hepatitis C prevention, support and research program 1999/2000-2005/2006. Available at:. http://www.phac-aspc.gc.ca/publicat/2008/er-re-hepc/er-re-hepc1-eng.php#ref Accessed March 9, 2009
90. Gully P.R., and Tepper M.L. Hepatitis C. CMAJ 156 10 (1997) 1427-1430
91. Ono-Nita S.K., Nita M.E., and Carrilho F.J. Hepatitis C: facts in numbers. Arq Gastroenterol 43 2 (2006) 71-72
92. Santos-Lopez G., Sosa-Jurado F., Vallejo-Ruiz V., et al. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infect 56 4 (2008) 281-290
93. Chiquete E., and Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: a systematic review. Intervirology 50 1 (2007) 1-8
94. Madhava V., Burgess C., and Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2 5 (2002) 293-302
95. Jeannel D., Fretz C., Traore Y., et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 55 2 (1998) 92-97
96. Simonsen L., Kane A., Lloyd J., et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 77 10 (1999) 789-800
97. Gibb D.M., Goodall R.L., Dunn D.T., et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 356 9233 (2000) 904-907
98. ECDC. Annual epidemiological report on communicable diseases in Europe 2008. Available at:. http://ecdc.europa.eu/en/files/pdf/Publications/081215_AER_long_2008.pdf Accessed March 4, 2009
99. Esteban J.I., Sauleda S., and Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48 1 (2008) 148-162
100. Strickland G.T., Elhefni H., Salman T., et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 67 4 (2002) 436-442
101. Strickland G.T. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43 5 (2006) 915-922
102. Frank C., Mohamed M.K., Strickland G.T., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 9207 (2000) 887-891
103. Nafeh M.A., Medhat A., Shehata M., et al. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 63 5-6 (2000) 236-241
104. Raza S.A., Clifford G.M., and Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 96 7 (2007) 1127-1134
105. Ramia S., and Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 10 4 (2006) 272-277
106. Raja N.S., and Janjua K.A. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 41 1 (2008) 4-8
107. Khaja M.N., Munpally S.K., Hussain M.M., et al. Hepatitis C virus: the Indian scenario. Curr Sci 83 3 (2002) 219-224
108. Mukhopadhya A. HCV: the Indian scenario. Trop Gastroenterol 27 3 (2006) 105-110
109. Jha J., Banerjee K., and Arankalle V.A. A high prevalence of antibodies to hepatitis C virus among commercial plasma donors from Western India. J Viral Hepat 2 5 (1995) 257-260
110. Nandi J., Bhawalkar V., Mody H., et al. Detection of HIV-1, HBV and HCV antibodies in blood donors from Surat, western India. Vox Sang 67 4 (1994) 406-407
111. Chowdhury A., Santra A., Chaudhuri S., et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 37 4 (2003) 802-809
112. WHO Regional Office for South-East Asia. Blood safety and clinical technology. Policy guidelines on HCV testing report of an informal consultation, New Delhi, 21-22nd December, 1999. Available at:. http://www.searo.who.int/en/Section10/Section17/Section58/Section220_217.htm Accessed March 11, 2009
113. Hazra S.C., Chatterjee S., Das Gupta S., et al. Changing scenario of transfusion-related viral infections. J Assoc Physicians India 50 (2002) 879-881
114. Wiwanitkit V. Anti HCV seroprevalence among the voluntary blood donors in Thailand. Hematology 10 5 (2005) 431-433
115. Luksamijarulkul P., Thammata N., Sujirarat D., et al. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health 35 1 (2004) 147-154
116. Tanwandee T., Piratvisuth T., Phornphutkul K., et al. Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study. J Med Assoc Thai 89 Suppl 5 (2006) S79-S83
117. Jittiwutikarn J., Thongsawat S., Suriyanon V., et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg 74 6 (2006) 1111-1116
118. Hansurabhanon T., Jiraphongsa C., Tunsakun P., et al. Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand. Ann Trop Med Parasitol 96 6 (2002) 615-625
119. Luksamijarulkul P., and Deangbubpha A. Hepatitis C antibody prevalence and risk factors of some female sex workers in Thailand. Southeast Asian J Trop Med Public Health 28 3 (1997) 507-512
120. Sulaiman H.A., Julitasari, Sie A., et al. Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors. Trans R Soc Trop Med Hyg 89 2 (1995) 167-170
121. Kyi K.P., Aye M., Oo K.M., et al. Population and patients with liver ailments in Myanmar. Reg Health Forum 6 1 (2002) 1-6. http://www.searo.who.int/EN/Section1243/Section1310/Section1343/Section1344/Section1355_5302.htm Accessed March 11, 2009
122. Garten R.J., Lai S., Zhang J., et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33 1 (2004) 182-188
123. Xia X., Luo J., Bai J., et al. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 122 10 (2008) 990-1003
124. Higuchi M., Tanaka E., and Kiyosawa K. Epidemiology and clinical aspects on hepatitis C. Jpn J Infect Dis 55 3 (2002) 69-77
125. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 62 Suppl 1 (2002) 8-17
126. Iino S. Relationship between infection with hepatitis C virus and hepatocellular carcinoma in Japan. Antivir Ther 3 Suppl 3 (1998) 143-146
127. Law M.G., Dore G.J., Bath N., et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 32 5 (2003) 717-724
128. Dore G.J., Law M., MacDonald M., et al. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 26 2 (2003) 171-184
129. Armstrong G.L., Williams I.T., Maga U.A., et al. Hepatitis C virus infection in Samoa and American Samoa. Am J Trop Med Hyg 74 2 (2006) 261-262
130. Gacic-Dobo M., Mayers G., Birmingham M., et al. Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep 52 36 (2003) 868-870